Randomized Double Blind Placebo Control Study in Patients With Schizophrenia
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Negative symptoms and cognitive deficits are two partially-related features of schizophrenia
which have a major negative impact on social function and objective quality of life. Standard
drug treatments have little impact on either and arguably no effect on primary negative
symptoms. Social dysfunction has major economic consequences in both the developed and
developing world. There is evidence that anti-inflammatory treatment may have beneficial
effects in patients with schizophrenia.
Phase:
Phase 2
Details
Lead Sponsor:
Pakistan Institute of Learning and Living Pakistan Institute of Living and Learning
Collaborators:
Abbasi Shaheed Hospital Dow University of Health Sciences Karwan e Hayat Stanley Medical Research Institute